{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-22-000571","form_type":"8-K","ticker":"CVSA","cik":"0000730464","company_name":"Covista Inc.","filed_at":"2022-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.507249+00:00","generated_at":"2026-06-26T00:07:01.504431+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Adtalem Q3 EPS $7.09; raises FY22 adjusted EPS guidance to $3.15-$3.35","bullets":["Revenue $365.6M (+58.8% YoY); adjusted diluted EPS from cont. ops $0.87 vs $0.60 prior year.","Completed $1B divestiture of Financial Services segment; used $770M to reduce debt by 46.7%.","Repurchased 4.7M shares for $150M; board authorized $300M share repurchase over 36 months.","FY22 guidance: adjusted revenue $1.35B-$1.39B; adjusted diluted EPS raised to $3.15-$3.35.","Chamberlain op income +2.4% despite revenue decline; Medical/Vet adjusted op income +30.1%."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-22-000571","json":"https://secwatch.observer/filing/0001157523-22-000571.json","markdown":"https://secwatch.observer/filing/0001157523-22-000571.md","text":"https://secwatch.observer/filing/0001157523-22-000571.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/730464/000115752322000571/0001157523-22-000571-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/730464/000115752322000571/a52709600.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T00:07:01.504431+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}